Search for: "Abbott Laboratoires" Results 1 - 7 of 7
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 May 2019, 4:00 am by Steve Matthews
Laboratoires Abbott limitée, 2019 QCCA 801Juridiction : Cour d’appel (C.A.), Québec, 200-09-009393-163Décision de : Juges Allan R. [read post]
15 May 2019, 4:00 am by Administrator
Laboratoires Abbott limitée, 2019 QCCA 801 [[136] Le fabricant d’un produit pharmaceutique a le devoir de mettre en garde les patients des effets secondaires potentiellement dangereux qu’il connaît ou qu’il devrait connaître lors de la commercialisation, et en continu par la suite, au fur et à mesure de l’avancée des connaissances scientifiques et des données postcommercialisation[85]. [137] Comme indiqué, selon… [read post]
8 Dec 2010, 2:20 am by Marie Louise
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar (Temozolomide) – US:… [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting Sandoz from distributing… [read post]